Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cell Therapy Catapult Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10483
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Therapy Catapult Ltd (Catapult) is a provider of cell and gene therapy life cycle solutions. The company offers services such as industrialization, manufacturing, regulatory, health economics and market access, non-clinical safety and clinical operations. Its health economics and market access provide pricing and reimbursement and commercial management for gene therapies and other types of therapies. Catapult provides technology platform and clinical trials. The company also offers reimbursement and adoption of therapies. It partners healthcare sector and clinical researchers. Catapult is headquartered in London, the UK.

Cell Therapy Catapult Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Therapy Catapult Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Cell Therapy Catapult Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 10
Cell Therapy Catapult Enters into Agreement with Asymptote 11
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 12
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 13
Cell Therapy Catapult Ltd – Key Competitors 14
Cell Therapy Catapult Ltd – Key Employees 15
Cell Therapy Catapult Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Recent Developments 17
Strategy And Business Planning 17
Apr 23, 2018: Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in the UK 17
Corporate Communications 19
Oct 18, 2018: CGT Catapult names Three New Board Members 19
Jun 06, 2018: Cell and Gene Therapy Catapult Appoints Dr Jonathan Appleby As Chief Scientific Officer 21
Other Significant Developments 22
Feb 28, 2018: CGT Catapult holds inaugural Seminar Series 22
Nov 13, 2017: Cell and Gene Therapy Catapult research highlights the UK’s growing global leadership in innovative cell and gene therapy industry 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Cell Therapy Catapult Ltd, Medical Equipment, Key Facts, 2017 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Therapy Catapult Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Deals By Market, 2012 to YTD 2018 8
Cell Therapy Catapult Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Asymptote Enters into Licensing Agreement with Cell and Gene Therapy Catapult 10
Cell Therapy Catapult Enters into Agreement with Asymptote 11
Cell Therapy Catapult, Azellon, University of Liverpool and NHS Blood and Transplant Enter into Agreement 12
ReNeuron Enters Into Co-Development Agreement With Cell Therapy Catapult 13
Cell Therapy Catapult Ltd, Key Competitors 14
Cell Therapy Catapult Ltd, Key Employees 15
Cell Therapy Catapult Ltd, Subsidiaries 16
Cell Therapy Catapult Ltd, Joint Venture 16

List of Figures
Cell Therapy Catapult Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Cell Therapy Catapult Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Cell Therapy Catapult Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Cell Therapy Catapult Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Cell Therapy Catapult Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Brighthouse Financial, Inc. (BHF):企業の財務・戦略的SWOT分析
    Brighthouse Financial, Inc. (BHF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Dover Corp (DOV):企業の財務・戦略的SWOT分析
    Dover Corp (DOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Circassia Pharmaceuticals Plc (CIR):医療機器:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • equensWorldline SE:企業の戦略・SWOT・財務情報
    equensWorldline SE - Strategy, SWOT and Corporate Finance Report Summary equensWorldline SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Amey Plc:企業の戦略的SWOT分析
    Amey Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • aTyr Pharma Inc (LIFE)-製薬・医療分野:企業M&A・提携分析
    Summary aTyr Pharma Inc (aTyr Pharma) is a biotherapeutics company that discovers and develops physiocrine-based therapies. The company’s resolaris is a potential intravenous protein therapeutic for the treatment of rare myopathies with an immune component. It offers phyisiocrine, which is a class o …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • VSTECS Holdings Ltd:企業の戦略・SWOT・財務情報
    VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary VSTECS Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eisai Inc-製薬・医療分野:企業M&A・提携分析
    Summary Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company's major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemoth …
  • STADA Arzneimittel AG:企業の戦略・SWOT・財務情報
    STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report Summary STADA Arzneimittel AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Trusted Media Brands Inc:企業の戦略的SWOT分析
    Trusted Media Brands Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Nova Eye Medical Ltd (EYE):企業の財務・戦略的SWOT分析
    Nova Eye Medical Ltd (EYE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Fluxys SA:企業の戦略的SWOT分析
    Fluxys SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • UbiVac LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …
  • Vygon SA-医療機器分野:企業M&A・提携分析
    Summary Vygon SA (Vygon) is a medical specialty company that designs, manufactures and markets single use medical and surgical products. It offers products in the areas of paediatrics and neonatology, emergency and intensive care units, anaesthesia, support for post-operative pain relief, vascular a …
  • Public Broadcasting Service:企業の戦略的SWOT分析
    Public Broadcasting Service - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Physio-Control Inc:医療機器:M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • Mitsui O.S.K. Lines Ltd (9104)-石油・ガス分野:企業M&A・提携分析
    Summary Mitsui O.S.K. Lines Ltd (MOL) is a global marine logistic company. It owns and operates dry bulkers, tankers, LNG carriers, containerships, ferries & coastal RoRo ships, cruise ships. The company’s dry bulkers transport dry bulk cargo such as iron ore, coal, grains, wood, wood chips, cement, …
  • NorthWestern Corporation (NWE)-エネルギー分野:企業M&A・提携分析
    Summary NorthWestern Corporation, doing business as NorthWestern Energy, is an integrated electric utility which generates, transmits, and distributes electricity and distributes natural gas in South Dakota, Nebraska and Montana. It produces energy from wind, hydro, natural gas, and coal-fired sourc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆